Oral microbiome components predict response to neoadjuvant chemotherapy in triple-negative breast cancer patients
The oral microbiome has emerged as a critical biomarker and regulator in cancer development and treatment response, garnering increasing attention from researchers. However, its specific role in breast cancer, particularly in triple-negative breast cancer (TNBC), remains poorly understood. The influ...
Saved in:
| Main Authors: | Xiaoyan Fu, Ze Huang, Zongyan Li, Zuxiao Chen, Zhijie Wu, Qingyu Yang, Haiyan Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1546044/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Does T1c–2N0–1M0 triple negative breast cancer derive a benefit from neoadjuvant chemotherapy?
by: Ruiliang Chen, et al.
Published: (2024-12-01) -
Effect of HER2-low expression on the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer
by: Lin-Yu Xia, et al.
Published: (2025-06-01) -
Central nervous system relapse in triple-negative breast cancer patients achieving pathological complete response after neoadjuvant chemotherapy: A retrospective cohort analysis
by: Gabriel Berlingieri Polho, et al.
Published: (2025-10-01) -
Comprehensive genomic profiling can predict response to neoadjuvant chemotherapy in triple-negative breast cancer
by: Monika Drobniene, et al.
Published: (2025-04-01) -
Nomogram for the prediction of the prognosis of patients with triple-negative invasive ductal carcinoma of breast after neoadjuvant chemotherapy
by: Qiuyu Yang, et al.
Published: (2025-07-01)